BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 34542663)

  • 21. Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
    He J; Huang F; Zhang J; Chen Q; Zheng Z; Zhou Q; Chen D; Li J; Chen J
    J Med Virol; 2021 Apr; 93(4):2115-2131. PubMed ID: 33091154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
    Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR
    Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope-Based Potential Vaccine Candidate for Humoral and Cell-Mediated Immunity to Combat Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.
    Das BK; Chakraborty D
    J Phys Chem Lett; 2020 Nov; 11(22):9920-9930. PubMed ID: 33174418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.
    Campos DMO; Silva MKD; Barbosa ED; Leow CY; Fulco UL; Oliveira JIN
    Comput Biol Chem; 2022 Dec; 101():107754. PubMed ID: 36037724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
    Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
    J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
    Jain N; Shankar U; Majee P; Kumar A
    Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
    Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
    Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the S Protein of SARS-CoV-2 to Design a Novel Multi-Epitope Vaccine against COVID-19 Based on Immunoinformatics Approaches.
    Huang Z; Shi H; Gong H; Sun Q; Yang S; Zhang Y; Shi Z; Xia Z; Huang S; Yao S; Xu F
    Front Biosci (Landmark Ed); 2024 May; 29(5):196. PubMed ID: 38812300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.
    Ahammad I; Lira SS
    Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine.
    Akhand MRN; Azim KF; Hoque SF; Moli MA; Joy BD; Akter H; Afif IK; Ahmed N; Hasan M
    Infect Genet Evol; 2020 Nov; 85():104517. PubMed ID: 32882432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of a multi-epitope-based vaccine consisted of immunodominant epitopes of structural proteins of SARS-CoV-2 using immunoinformatics approach.
    Mahmoudvand S; Esmaeili Gouvarchin Ghaleh H; Jalilian FA; Farzanehpour M; Dorostkar R
    Biotechnol Appl Biochem; 2023 Jun; 70(3):1189-1205. PubMed ID: 36577011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoinformatics approaches for designing a novel multi epitope peptide vaccine against human norovirus (Norwalk virus).
    Azim KF; Hasan M; Hossain MN; Somana SR; Hoque SF; Bappy MNI; Chowdhury AT; Lasker T
    Infect Genet Evol; 2019 Oct; 74():103936. PubMed ID: 31233780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
    Jyotisha ; Singh S; Qureshi IA
    J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
    PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach.
    Mahmud S; Rafi MO; Paul GK; Promi MM; Shimu MSS; Biswas S; Emran TB; Dhama K; Alyami SA; Moni MA; Saleh MA
    Sci Rep; 2021 Jul; 11(1):15431. PubMed ID: 34326355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modelling on multiepitope-based vaccine against SARS-CoV-2 using immunoinformatics, molecular docking, and molecular dynamics simulation.
    Arwansyah A; Arif AR; Kade A; Taiyeb M; Ramli I; Santoso T; Ningsih P; Natsir H; Tahril T; Uday Kumar K
    SAR QSAR Environ Res; 2022 Sep; 33(9):649-675. PubMed ID: 36083166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.